Hidden in Plain Sight: Well-Known Drug Could Yield New Treatment for Herpes Viruses
University of Utah HealthIn a search for new antiviral drugs, University of Utah scientists found that a common heart failure medicine, spironolactone, has an unexpected ability to block Epstein Barr virus (EBV), a herpesvirus that causes mononucleosis. The drug blocks a key step in viral infection common to all herpesviruses, revealing that it could be developed into a new class of drug to treat herpesvirus infections including herpes, shingles, and mono. The research was published in PNAS.